BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/10/2022 8:23:14 AM | Browse: 865 | Download: 1767
Publication Name World Journal of Gastroenterology
Manuscript ID 75340
Country Italy
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures
Manuscript Source Invited Manuscript
All Author List Paolo Gallo, Francesca Terracciani, Giulia Di Pasquale, Matteo Esposito, Antonio Picardi and Umberto Vespasiani-Gentilucci
ORCID
Author(s) ORCID Number
Paolo Gallo http://orcid.org/0000-0001-8292-1134
Francesca Terracciani http://orcid.org/0000-0002-4778-4194
Giulia Di Pasquale http://orcid.org/0000-0001-8872-6815
Matteo Esposito http://orcid.org/0000-0003-0609-6333
Antonio Picardi http://orcid.org/0000-0002-0230-218X
Umberto Vespasiani-Gentilucci http://orcid.org/0000-0002-1138-1967
Funding Agency and Grant Number
Corresponding Author Paolo Gallo, MD, Associate Research Scientist, Doctor, Doctor, Clinical Medicine and Hepatology Unit, Campus Bio-Medico University, Via Alvaro del Portillo, 200, Roma 00128, Italy. paolo.gallo@policlinicocampus.it
Key Words Thrombocytopenia; Chronic liver disease; Thrombopoietin agonists; Platelet transfusions; Avatrombopag; Lusutrombopag
Core Tip Recent advances have shed light on the pathophysiology of thrombocytopenia in chronic liver disease and on the key role of thrombopoietin (TPO). Severe thrombocytopenia complicates the management of patients with liver disease by increasing the potential risk of bleeding for invasive procedures, possibly delaying lifesaving interventions. In the very last years, novel agents such as the TPO-receptor agonists avatrombopag and lusutrombopag have been developed in order to increase platelet production as an alternative to platelet transfusions, with positive efficacy and safety outcomes.
Publish Date 2022-08-10 08:23
Citation Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U. Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures. World J Gastroenterol 2022; 28(30): 4061-4074
URL https://www.wjgnet.com/1007-9327/full/v28/i30/4061.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i30.4061
Full Article (PDF) WJG-28-4061.pdf
Full Article (Word) WJG-28-4061.docx